LVW Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$637K Sell
8,138
-5,237
-39% -$422K 0.06% 193
2026
Q1
$1.16M Sell
13,375
-16,120
-55% -$1.54M 0.11% 101
2025
Q4
$2.83M Sell
29,495
-1,415
-5% -$137K 0.29% 45
2025
Q3
$2.94M Buy
30,910
+3,021
+11% +$278K 0.3% 45
2025
Q2
$2.43M Buy
27,889
+3,290
+13% +$279K 0.27% 51
2025
Q1
$2.21M Buy
24,599
+4,892
+25% +$438K 0.26% 51
2024
Q4
$1.57M Buy
19,707
+1,358
+7% +$118K 0.19% 79
2024
Q3
$1.65M Buy
18,349
+6,231
+51% +$524K 0.21% 75
2024
Q2
$954K Sell
12,118
-3,774
-24% -$309K 0.14% 99
2024
Q1
$1.38M Buy
15,892
+3,271
+26% +$279K 0.23% 71
2023
Q4
$1.04M Sell
12,621
-7,437
-37% -$567K 0.19% 82
2023
Q3
$1.57M Sell
20,058
-9,407
-32% -$787K 0.32% 67
2023
Q2
$2.6M Sell
29,465
-1,110
-4% -$95.6K 0.5% 56
2023
Q1
$2.46M Buy
30,575
+6,612
+28% +$539K 0.48% 53
2022
Q4
$1.86M Sell
23,963
-3,028
-11% -$245K 0.38% 67
2022
Q3
$2.18M Sell
26,991
-506
-2% -$45.5K 0.49% 55
2022
Q2
$2.47M Buy
27,497
+2,254
+9% +$228K 0.5% 56
2022
Q1
$2.8M Buy
25,243
+1,418
+6% +$150K 0.47% 57
2021
Q4
$2.46M Sell
23,825
-1,649
-6% -$191K 0.42% 53
2021
Q3
$3.19M Sell
25,474
-28
-0.1% -$3.62K 0.55% 50
2021
Q2
$3.17M Sell
25,502
-658
-3% -$82.6K 0.56% 50
2021
Q1
$3.09M Sell
26,160
-157
-0.6% -$18.4K 0.59% 49
2020
Q4
$3.08M Buy
26,317
+861
+3% +$94.8K 0.62% 43
2020
Q3
$2.65M Buy
25,456
+448
+2% +$45K 0.58% 49
2020
Q2
$2.29M Buy
+25,008
New +$2.4M 0.55% 48

Other funds holding MDT

LVW Advisors's MDT Position: Q2 2026 in Review

LVW Advisors reduced its Medtronic (MDT) stake by 39% in Q2 2026, selling an estimated $422K and leaving 8,138 shares worth $637K. The position accounts for 0.06% of the portfolio, ranked #193.

LVW Advisors first reported a position in MDT in Q2 2020 and has held it in 25 quarters since. The position peaked at $3.19M in Q3 2021. 961 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • LVW Advisors held 8,138 shares of Medtronic worth $637K as of Q2 2026.
  • LVW Advisors sold 5,237 Medtronic shares in Q2 2026, an estimated $422K.
  • Medtronic made up 0.06% of LVW Advisors's portfolio in Q2 2026, its #193 holding.
  • LVW Advisors first reported a position in Medtronic in Q2 2020 and has held it in 25 quarters since.
  • LVW Advisors's Medtronic position peaked at $3.19M in Q3 2021.
  • 961 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on LVW Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.